PT - JOURNAL ARTICLE AU - Ruth Johnson AU - Yi Ding AU - Vidhya Venkateswaran AU - Arjun Bhattacharya AU - Alec Chiu AU - Tommer Schwarz AU - Malika Freund AU - Lingyu Zhan AU - Kathryn S. Burch AU - Christa Caggiano AU - Brian Hill AU - Nadav Rakocz AU - Brunilda Balliu AU - Jae Hoon Sul AU - Noah Zaitlen AU - Valerie A. Arboleda AU - Eran Halperin AU - Sriram Sankararaman AU - Manish J. Butte AU - UCLA Precision Health Data Discovery Repository Working Group AU - UCLA Precision Health ATLAS Working Group AU - Clara Lajonchere AU - Daniel H. Geschwind AU - Bogdan Pasaniuc TI - Leveraging genomic diversity for discovery in an EHR-linked biobank: the UCLA ATLAS Community Health Initiative AID - 10.1101/2021.09.22.21263987 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.22.21263987 4099 - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263987.short 4100 - http://medrxiv.org/content/early/2021/09/23/2021.09.22.21263987.full AB - Large medical centers located in urban areas such as Los Angeles care for a diverse patient population and offer the potential to study the interplay between genomic ancestry and social determinants of health within a single medical system. Here, we introduce the UCLA ATLAS Community Health Initiative – a biobank of genomic data linked with de-identified electronic health records (EHRs) of UCLA Health patients. We leverage the unique genomic diversity of the patient population in ATLAS to explore the interplay between self-reported race/ethnicity and genetic ancestry within a disease context using phenotypes extracted from the EHR. First, we identify an extensive amount of continental and subcontinental genomic diversity within the ATLAS data that is consistent with the global diversity of Los Angeles; this includes clusters of ATLAS individuals corresponding to individuals with Korean, Japanese, Filipino, and Middle Eastern genomic ancestries. Most importantly, we find that common diseases and traits stratify across genomic ancestry clusters, thus suggesting their utility in understanding disease biology across diverse individuals. Next, we showcase the power of genetic data linked with EHR to perform ancestry-specific genome and phenome-wide scans to identify genetic factors for a variety of EHR-derived phenotypes (phecodes). For example, we find ancestry-specific associations for liver disease, and link the genetic variants with neurological and neoplastic phenotypes primarily within individuals of admixed ancestries. Overall, our results underscore the utility of studying the genomes of diverse individuals through biobank-scale genotyping efforts linked with EHR-based phenotyping.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Patient Recruitment and Sample Collection for Precision Health Activities at UCLA is an approved study by the UCLA Institutional Review Board (UCLA IRB). IRB#17-001013.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndividual electronic health record data and genomic data are not publicly available due to patient confidentiality and security concerns.